Health and Social Needs

Bayer is committed to fight the Chagas disease

Chagas disease is a deadly tropical disease that is widespread in many countries of Central and South America. The pathogen is transmitted by blood-sucking insects, blood transfusions with infected blood– or even during pregnancy if the mother is suffering from the disease.

People hardly know about Chagas disease. Early education in school is essiantally for precaution.

People hardly know about Chagas disease. Early education in school is essiantally for precaution.

Bayer HealthCare and the World Health Organization (WHO) since 2004 have been partners in the fight against Chagas disease. In March 2011 the company has signed an extension of its agreement with the World Health Organization (WHO) to fight the parasitic infection.

 

By concluding the agreement, Bayer HealthCare underlines its commitment to its successful collaboration with WHO and ensures that ongoing projects and initiatives can continue beyond the initial timeline. Bayer HealthCare has also committed to doubling its initial donation of 2.5 million Lampit™ tablets (active ingredient: nifurtimox) for the treatment of Chagas disease to a total of 5 million by 2017. In addition, the company will contribute 1.5 million US dollars in cash to fund logistics and distribution.

Furthermore, the Bayer Cares Foundation, Bayer HealthCare and Caritas Argentina cooperate to combat the Chagas disease in Argentina. Starting in 2013, the join forces for four years to educate people about the disease, improve early diagnosis in rural areas of Argentina, and make the population more aware of ways in which they can protect themselves. The Bayer Foundation funds the project with EUR 665,000.

Under the project designed by Bayer HealthCare potentials Caritas and corporate staff visit schools in rural areas, which are often cut off from healthcare services, to provide comprehensive and age-appropriate, on-the-spot education about Chagas disease. Children and youth represent a particularly vulnerable risk group who can also pass on what they learn to their families. To increase the people's knowledge about how the disease spreads, blood tests for diagnosing people infected with the disease are conducted, especially in remote areas. A project office in Buenos Aires will pool the findings and, in close collaboration with the public health authorities, subject the data to further analysis and use it to develop preventive measures.

Bayer HealthCare and twelve other pharmaceutical companies jointly signed the London Declaration on Neglected Tropical Diseases, which has set itself the goal of controlling or eliminating ten neglected tropical diseases.

Last updated: February 28, 2014  Copyright © Bayer AG
http://www.bayer.com